TrialJournal for immunotherapy of cancer2019

A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.

Rosa Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.